Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
Astellas Pharma Global Development, Inc.
Thomas Powles; Begoña P Valderrama; Shilpa Gupta; Jens Bedke; Eiji Kikuchi; Jean Hoffman-Censits; Gopa Iyer; Christof Vulsteke; Se Hoon Park; Sang Joon Shin; Daniel Castellano; Giuseppe Fornarini; Jian-Ri Li; Mahmut Gümüş; Nataliya Mar; Yohann Loriot; Aude Fléchon; Ignacio Duran; Alexandra Drakaki; Sujata Narayanan; Xuesong Yu; Seema Gorla; Blanca Homet Moreno; Michiel S van der Heijden; EV-302 Trial Investigators